Figure 1.
Eligibility of sodium–glucose co‐transporter‐2 inhibitor therapies based on clinical trial and Food and Drug Administration (FDA) eligibility criteria.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.